ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FSD Receives FDA Approval to Design Trial for COVID-19 Treatment
June 15, 2020FSD Pharma announced the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus. -
FSD Pharma gets FDA nod to design Covid-19 trial with ultramicronised PEA
June 05, 2020FSD Pharma has secured approval from the US Food and Drug Administration (FDA) to design a phase 2a clinical trial to evaluate the efficacy of FSD-201 ... -
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial
June 04, 2020To evaluate FSD-201 to treat COVID-19; anti-inflammatory properties aim to avoid the cytokine storm.
Pharma Sources Insight January 2025
